Pharmacy Information

Pharmacy Updates

The purpose of CalOptima educational bulletins is to increase providers’ understanding of current treatment guidelines and recommendations on drugs, disease states, and medical conditions. Specific recommendations are made with each article on how to improve the quality of care for CalOptima members.

For more information about the CalOptima Pharmacy Program, please call Pharmacy Management at 1-714-246-8471.

October 2019: Self-Monitoring of Blood Glucose 

September 2019: Follow-Up Care for Children Prescribed ADHD Medication 

August 2019: FDA Adds Boxed Warning to Sedative Hypnotics 

July 2019: Co-prescribing Naloxone with Opioids  

June 2019: Vitamin D Supplementation Overuse in Adults 

May 2019: Beers Criteria Update 

April 2019: Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis 

March 2019: Safe Medication Disposal in the Community 

February 2019: Appropriate Use of Omega-3 Products 

January 2019: Deprescribing Benzodiazepines in Patients Receiving Opioids 

December 2018: Opioid Quality Measure Updates 

November 2018: Medical Assistance with Smoking and Tobacco Use Cessation 

October 2018: Annual Flu Vaccine Update 

Contact Us
  • If you have questions, you can contact the CalOptima Pharmacy Management department Monday through Friday from 8 a.m. to 4 p.m. at 1-714-246-8471.
Suggestions
Residency Program
  • The CalOptima PGY-1 Managed Care Pharmacy Residency program provides residents with a broad overview of managed care pharmacy practice at a county organized health system (COHS).

    Download the brochure
Formularies
Plan Profile Sheets
Pharmacy Benefit Manager is MedImpact
  • MedImpact administers CalOptima’s pharmacy program. It provides claims processing, pharmacy network management, prior authorization processing and drug utilization management services.

Download the free Adobe Reader.

Materials available on this Website in PDF format may require the free Adobe Reader to view. To download Adobe Reader for free from the Adobe Website, click here.